Summary of Action investigated 4Life Research LLC (“4Life”), a multilevel marketing company that sells and markets “Transfer Factor” supplements, as well as other products, and found that the company and its distributors are engaged in a deceptive marketing campaign.

Specifically, compiled over 140 examples of unsubstantiated health and disease-treatment claims made by 4Life distributors about the company’s products, such as being able to treat, cure, or alleviate the symptoms of autism, Tourette syndrome, pneumonia, cancer, dengue, diabetes, ADD, Down syndrome, Epstein-Barr virus, epilepsy, HIV/AIDS, heart disease, influenza, leprosy, leukemia, lupus, meningitis, Parkinson’s disease, and shingles.

As a result of these findings, sent a warning letter to 4Life on June 6, 2016 notifying it of’s findings and asking that the company remedy the deceptive marketing immediately.  The company responded the following week outlining the steps it had taken thus far with respect to the deceptive claims at issue, including the immediate suspension of numerous 4Life distributors.

Due to the company’s corrective actions and pledge to fully address the matter in short order, has not elevated its investigation by filing a complaint with the Federal Trade Commission at this time. However, will continue to monitor 4Life, its progress, and future marketing materials to determine if further action is needed.

Print Friendly, PDF & Email


Leave a Reply

Back to Top ↑